Screener
Taysha Gene Therapies, Inc. TSHA Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Taysha Gene Therapies, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344610
FAQ
- What is Taysha Gene Therapies, Inc.'s interest expense?
- Taysha Gene Therapies, Inc. (TSHA) reported interest expense of $6K in Q2 2026.
- How has Taysha Gene Therapies, Inc.'s interest expense changed year-over-year?
- Taysha Gene Therapies, Inc.'s interest expense decreased by 64.7% year-over-year, from $17K to $6K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s interest expense?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s interest expense has grown at a -54.2% compound annual growth rate (CAGR), from $1.43M to $63K.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Taysha Gene Therapies, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude